Repeated Autologous Mesenchymal Stem Cell Transplants Aid Cognition in Patients With Progressive MS
Hadassah Medical Organization (HMO) researchers have shown that patients with progressive multiple sclerosis (MS) have significant improvements in cognition, neurological function tests, and quality of life following repeated intrathecal injection of autologous, bone marrow-derived mesenchymal stem cells (MSC). Presenting their study to the Americas Committee for Treatment and Research in…